Knowledge Distillery

SARS-CoV-2 has currently precipitated the COVID-19 global health crisis.

Most human monoclonal antibodies (mAbs) neutralizing SARS-CoV-2 recognize the spike (S) protein receptor-binding domain and block virus interactions…

The SARS-CoV-2 spike (S) glycoprotein contains an immunodominant receptor-binding domain (RBD) targeted by most neutralizing antibodies (Abs) in…

The objective of this matched cohort study was to establish whether there is any change in mortality from infection with a new variant of SARS-CoV-2 ,…

Whilst respiratory failure in COVID-19 arises from severe interstitial lung involvement, SARS-CoV-2 likely spreads also through the nervous system.

The impact of the COVID‐19 pandemic on PD patients is yet to be determined. Studies showed diverse prevalence and outcomes among PD patients.

Studies suggest an increased risk of adverse outcomes among patients with acute ischemic stroke (AIS) and COVID-19.

Acute delirium and other neuropsychiatric symptoms have frequently been reported in COVID-19 patients and are variably referred to as acute…

This review focuses on new evidence supporting the global immunization strategy for MS patients receiving disease-modifying drugs (DMDs), including…

The purpose of this review was to provide an overview on current knowledge of neurological symptoms and complications of COVID-19, and to suggest…

The aim of this retrospective, international multicenter study was to assess the association between abnormal findings on chest and brain imaging in…

Whether and how SARS-CoV-2 outbreak affected in-hospital acute stroke care system is still matter of debate.